Plain-English translation of NCT07090668 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a non-invasive treatment called transcutaneous auricular vagal nerve stimulation (taVNS), which uses gentle electrical stimulation on the ear to help manage pain in children with sickle cell disease. The stimulation activates nerves in your ear that can help your body reduce pain, swelling, and depression—all of which make pain feel worse. Researchers want to see if this safe, drug-free approach can help kids in the hospital during painful sickle cell crises.
Most children with sickle cell disease rely on opioid medications (like morphine) to manage their pain, which can lead to dependence and other serious side effects over time. This trial exists because doctors need safer, non-medication options to help kids control their pain during crises.
You likely qualify if…
You likely don't qualify if…
When you are admitted to the hospital for a sickle cell pain crisis, doctors will place a small ear device that gently stimulates nerves in your ear to help reduce pain. Researchers will compare your pain and recovery during this hospitalization (while receiving the treatment) with records from your previous pain crisis hospitalizations (before the treatment existed). The study will track how much pain you experience, how much medication you need, and how quickly you recover.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States